Relivergen™- a New Natural Formula to Support and Protect Liver Health
Relivergen™ a new clinically proven liver health formula has been announced by Chrysalis Health & Beauty Limited. The marketing of Relivergen™ is a collaboration between the technology holder Phynova Group Limited and Chrysalis Health & Beauty UK Limited who are seeking distributors for Relivergen™ globally.
Nottingham, United Kingdom, November 30, 2010 --(PR.com)-- Liver health is a major concern for millions of people worldwide.
Phase II clinical trials to evaluate the effectiveness of this new naturally derived formula and demonstrate the clinical safety of Relivergen™ have been completed. The studies showed that Relivergen™ effectively increases vitality, improves mental health, lowers levels of liver enzymes associated with liver inflammation and has an excellent safety profile.
Chrysalis Director Mark Broughton commented, “The launch of Relivergen™ follows years of research and development work by the Phynova team; it is not only the effectiveness but also the excellent safety profile of Relivergen™ that makes it eminently suitable for supporting liver health.”
Relivergen™ is clinically proven and recommended for:-
· Improvement of overall liver health
· Anyone concerned that diet or environmental factors may be compromising liver function
Phynova are seeking distribution partners for the active health Ingredient and finished dosage form. Enquiries should be made to Phynova’s marketing partners Chrysalis Health & Beauty Business Solutions Limited for details of available markets for API and finished products formats.
About Phynova Group Limited: Phynova is a UK company developing prescription pharmaceuticals, OTC drugs (Traditional Medicinal Herbal Products) and functional ingredients for healthcare and personal care markets, that are derived from plants used in Chinese medicines. Phynova specializes in gastroenterology (including hepatology), metabolic disorders and anti-infectives. Phynova’s lead product for postoperative ileus is currently enrolling patients in a Phase II proof-of-concept clinical trial in China. Other products include a candidate for the symptoms of chronic hepatitis C, which has completed a Phase I/II trial in the US and a Phase II trial in the UK; and two further products, a topic antibacterial for MRSA and a treatment for obesity and non-alcoholic fatty liver disease, are targeted for entry to the clinic over the upcoming two years.
About Chrysalis Health & Beauty Business Solutions Limited. Chrysalis Health & Beauty is a UK company specialist in the sales and marketing of innovative ingredients and products for Pharma, nutraceutical and personal care sectors. For further information please visit www.relivergen.com or contact info@chrysalisweb.com.
###
Phase II clinical trials to evaluate the effectiveness of this new naturally derived formula and demonstrate the clinical safety of Relivergen™ have been completed. The studies showed that Relivergen™ effectively increases vitality, improves mental health, lowers levels of liver enzymes associated with liver inflammation and has an excellent safety profile.
Chrysalis Director Mark Broughton commented, “The launch of Relivergen™ follows years of research and development work by the Phynova team; it is not only the effectiveness but also the excellent safety profile of Relivergen™ that makes it eminently suitable for supporting liver health.”
Relivergen™ is clinically proven and recommended for:-
· Improvement of overall liver health
· Anyone concerned that diet or environmental factors may be compromising liver function
Phynova are seeking distribution partners for the active health Ingredient and finished dosage form. Enquiries should be made to Phynova’s marketing partners Chrysalis Health & Beauty Business Solutions Limited for details of available markets for API and finished products formats.
About Phynova Group Limited: Phynova is a UK company developing prescription pharmaceuticals, OTC drugs (Traditional Medicinal Herbal Products) and functional ingredients for healthcare and personal care markets, that are derived from plants used in Chinese medicines. Phynova specializes in gastroenterology (including hepatology), metabolic disorders and anti-infectives. Phynova’s lead product for postoperative ileus is currently enrolling patients in a Phase II proof-of-concept clinical trial in China. Other products include a candidate for the symptoms of chronic hepatitis C, which has completed a Phase I/II trial in the US and a Phase II trial in the UK; and two further products, a topic antibacterial for MRSA and a treatment for obesity and non-alcoholic fatty liver disease, are targeted for entry to the clinic over the upcoming two years.
About Chrysalis Health & Beauty Business Solutions Limited. Chrysalis Health & Beauty is a UK company specialist in the sales and marketing of innovative ingredients and products for Pharma, nutraceutical and personal care sectors. For further information please visit www.relivergen.com or contact info@chrysalisweb.com.
###
Contact
Chrysalis Health & Beauty Business Solutions Limited
Mark Broughton
+44 115 9771054
www.chrysalisweb.com
Mark Broughton
+44 115 9771054
www.chrysalisweb.com
Contact
Categories